Claritev Corp (CTEV) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2026. Claritev Corp is a healthcare technology, data, and insights company providing cost management, payment, and revenue integrity solutions to payers and third-party administrators. The company operates as a single reporting segment.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | Q2 2025 (3 Months) | YTD 2026 (6 Months) | YTD 2025 (6 Months) |
|---|---|---|---|---|
| Revenues | $257.5 million | $241.6 million | $502.2 million | $472.9 million |
| Operating Income | $23.4 million | $16.6 million | $30.0 million | $26.3 million |
| Net Loss (GAAP) | $(59.2) million | $(62.6) million | $(132.8) million | $(134.0) million |
| Adjusted EBITDA | $155.8 million | $154.0 million | $302.7 million | $296.1 million |
| Adjusted EPS | $1.41 | $1.44 | $2.37 | $2.66 |
| Cash & Equivalents | $14.4 million | $56.4 million | $14.4 million | $56.4 million |
| Restricted Cash | $13.3 million | $10.9 million | $13.3 million | $10.9 million |
| Total Debt (Gross) | $4.64 billion | $4.61 billion | $4.64 billion | $4.61 billion |
| Revolving Credit Availability | $273.6 million | $323.6 million | $273.6 million | $323.6 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 6.6% in Q2 and 6.2% YTD, driven primarily by a 13.7% increase in Claims Intelligence Solutions (Data iSight and Surprise Bill Services). This was partially offset by declines in Network Solutions (-7.0%) and Payment/Revenue Integrity (-5.9%).
- Operating Performance: Operating income improved 41.2% in Q2 to $23.4 million, despite higher costs of services (+11.3%) and G&A expenses (+8.4%).
- Expense Drivers: G&A expenses increased significantly due to $3.8 million in legal expenses related to antitrust matters and $1.3 million in transformation costs. Personnel expenses in Cost of Services rose 14.1%.
- Interest Expense: Interest expense remained relatively stable in Q2 but increased 4.4% YTD to $199.8 million, largely due to PIK interest charges increasing average indebtedness.
- Cash Flow: Operating cash flow improved to $46.9 million YTD (up from $31.2 million prior year). Investing cash outflows increased to $84.8 million due to technology investments for transformation initiatives.
Guidance, Outlook, Risks, and Unusual Items
- Legal Proceedings: The company is defending against consolidated federal antitrust lawsuits alleging conspiracy with payers to suppress out-of-network reimbursements. Discovery is ongoing. Additionally, a DOJ antitrust grand jury investigation was closed in June 2026 with no criminal charges, though a civil investigative demand remains open.
- Internal Controls: The company disclosed that disclosure controls and procedures were not effective as of June 30, 2026, due to unremediated material weaknesses in IT general controls (specifically program change management and user access controls). A remediation plan is underway.
- Client Concentration: One client accounted for 35.0% of revenue in Q2 2026, presenting a concentration risk.
- Debt Structure: The company maintains a complex capital structure with significant long-term debt ($4.64 billion). It is currently in compliance with all debt covenants.
- Share Repurchases: The company repurchased 136,216 shares in Q2 under a $75 million program approved in December 2025, with approximately $71.5 million remaining available.
Investor Verification Checklist
- Antitrust Litigation Status: Monitor the progress of the consolidated federal antitrust lawsuits and the outcome of the ongoing DOJ civil investigation.
- IT Control Remediation: Verify the timeline and effectiveness of the remediation plan for the material weaknesses in IT general controls.
- Client Concentration: Assess the stability of the relationship with the single client representing 35% of Q2 revenue.
- Debt Servicing: Review the impact of high interest rates and PIK interest on future liquidity and cash flow requirements.
- Transformation Costs: Evaluate the sustainability of "Transformation costs" ($21.0 million YTD) and their impact on future Adjusted EBITDA.